Plasmodium falciparum PfSET7: enzymatic characterization and cellular localization of a novel protein methyltransferase in sporozoite, liver and erythrocytic stage parasites
Citations Over TimeTop 10% of 2016 papers
Abstract
Epigenetic control via reversible histone methylation regulates transcriptional activation throughout the malaria parasite genome, controls the repression of multi-copy virulence gene families and determines sexual stage commitment. Plasmodium falciparum encodes ten predicted SET domain-containing protein methyltransferases, six of which have been shown to be refractory to knock-out in blood stage parasites. We have expressed and purified the first recombinant malaria methyltransferase in sufficient quantities to perform a full enzymatic characterization and reveal the ill-defined PfSET7 is an AdoMet-dependent histone H3 lysine methyltransferase with highest activity towards lysines 4 and 9. Steady-state kinetics of the PfSET7 enzyme are similar to previously characterized histone methyltransferase enzymes from other organisms, however, PfSET7 displays specific protein substrate preference towards nucleosomes with pre-existing histone H3 lysine 14 acetylation. Interestingly, PfSET7 localizes to distinct cytoplasmic foci adjacent to the nucleus in erythrocytic and liver stage parasites, and throughout the cytoplasm in salivary gland sporozoites. Characterized recombinant PfSET7 now allows for target based inhibitor discovery. Specific PfSET7 inhibitors can aid in further investigating the biological role of this specific methyltransferase in transmission, hepatic and blood stage parasites, and may ultimately lead to the development of suitable antimalarial drug candidates against this novel class of essential parasite enzymes.
Related Papers
- → Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a(2014)185 cited
- → Tug of war: adding and removing histone lysine methylation in Arabidopsis(2016)168 cited
- → Transcriptional regulation by methyltransferases and their role in the heart: highlighting novel emerging functionality(2020)17 cited
- → Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors(2007)56 cited
- → Controlling the Controllers: Regulation of Histone Methylation by Phosphosignalling(2020)21 cited